PROCEPT BioRobotics Corp reported the quarter ended March 31, 2026 results: revenue $83.1 million, net income Net loss was $31.6 million. Guidance reaffirmed.
“accountability, and commercial discipline, and our first quarter results reflect the early impact of that work," said Larry Wood, Chief Executive Officer. "We delivered $83.1 million in revenue, driven by strong U.S. system sales and improved pricing." Wood continued: “Aquablation® users completed approximately 12,200 U.S. procedures in the first quarter of”
Thomas M. Prescott was appointed as Chairperson of the Board at PROCEPT BioRobotics Corp.
“On July 18, 2024, the Board appointed Mr. Thomas M. Prescott as a new member of the Board and as the chairperson of the Board, with such appointment effective July 18, 2024.”
Thomas Krummel resigned as Director at PROCEPT BioRobotics Corp.
“On July 18, 2024, D r. Thomas Krummel notified the board of directors (the “Board”) of PROCEPT BioRobotics Corporation (the “Company”) that he intends to resign as a member of the Board and as a member of the Compensation Committee of the Board, effective at the conclusion of the Board meeting on July 18, 2024.”
Earnings Releases
PROCEPT BioRobotics Corp reported financial results for the quarter ended March 31, 2024.
“On May 1, 2024 , PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2024 .”
Larry Wood was appointed as Director at PROCEPT BioRobotics Corp.
“the Board appointed Mr. Larry Wood as a new member of the Board and as a member of the Audit Committee of the Board, with such appointment effective April 18, 2024.”
Colby Wood resigned as Director at PROCEPT BioRobotics Corp.
“Mr. Colby Wood notified the board of directors (the "Board") of PROCEPT BioRobotics Corporation (the "Company") that he intends to resign as a member of the Board and as a member of the Audit Committee of the Board, effective at the conclusion of the Board meeting on April 18, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.